Sunmax Biotechnology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 10.53%

Sunmax Biotechnology Co Ltd (4728) has an Asset Resilience Ratio of 10.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Sunmax Biotechnology Co Ltd (4728) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

NT$200.00 Million

≈ $6.30 Million USD Cash + Short-term Investments

Total Assets

NT$1.90 Billion

≈ $59.82 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Sunmax Biotechnology Co Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Sunmax Biotechnology Co Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Sunmax Biotechnology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sunmax Biotechnology Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$200.00 Million	10.53%
Total Liquid Assets	NT$200.00 Million	10.53%

Asset Resilience Insights

Moderate Liquidity: Sunmax Biotechnology Co Ltd has 10.53% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Sunmax Biotechnology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Sunmax Biotechnology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Abivax SA PA:ABVX	Biotechnology	2.34%
Nanobiotix S.A PA:NANO	Biotechnology	53.40%

Annual Asset Resilience Ratio for Sunmax Biotechnology Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Sunmax Biotechnology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.86%	NT$90.00 Million ≈ $2.84 Million	NT$1.85 Billion ≈ $58.31 Million	-0.10pp
2023-12-31	4.96%	NT$107.10 Million ≈ $3.37 Million	NT$2.16 Billion ≈ $68.02 Million	-7.72pp
2022-12-31	12.68%	NT$227.37 Million ≈ $7.16 Million	NT$1.79 Billion ≈ $56.50 Million	+7.50pp
2021-12-31	5.17%	NT$76.79 Million ≈ $2.42 Million	NT$1.48 Billion ≈ $46.75 Million	-4.43pp
2020-12-31	9.60%	NT$131.01 Million ≈ $4.13 Million	NT$1.36 Billion ≈ $42.98 Million	-3.38pp
2019-12-31	12.98%	NT$144.42 Million ≈ $4.55 Million	NT$1.11 Billion ≈ $35.05 Million	-14.99pp
2018-12-31	27.97%	NT$211.95 Million ≈ $6.68 Million	NT$757.89 Million ≈ $23.88 Million	+8.08pp
2017-12-31	19.88%	NT$131.40 Million ≈ $4.14 Million	NT$660.92 Million ≈ $20.82 Million	+17.70pp
2016-12-31	2.19%	NT$13.06 Million ≈ $411.43K	NT$597.49 Million ≈ $18.82 Million	--

pp = percentage points

About Sunmax Biotechnology Co Ltd

TWO:4728 Taiwan Biotechnology

Market Cap

$648.60 Million

NT$20.59 Billion TWD

Market Cap Rank

#10992 Global

#410 in Taiwan

Share Price

NT$378.00

Change (1 day)

+0.40%

52-Week Range

NT$373.00 - NT$450.00

All Time High

NT$494.50